Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography

Circulation

Volumn 121, Issue 15, 2010, Pages 1756-1767

  Geleijnse, Marcel L ^a   Krenning, Boudewijn J ^a   Nemes, Attila ^a   Van Dalen, Bas M ^a   Soliman, Osama I I ^a   Ten Cate, Folkert J ^a   Schinkel, Arend F L ^a   Boersma, Eric ^a   Simoons, Maarten L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Complications; Dobutamine; Safety; Stress echocardiography

Indexed keywords

ADENOSINE; AMIODARONE; ANTIHISTAMINIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DOBUTAMINE; GLYCERYL TRINITRATE; METOPROLOL; PHENTOLAMINE MESYLATE; PHYSOSTIGMINE; PROCAINAMIDE; VERAPAMIL;

ACUTE HEART INFARCTION; ANGIOPLASTY; ASYSTOLE; ATRIOVENTRICULAR BLOCK; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY SPASM; DRUG WITHDRAWAL; DYSPNEA; EXTRAVASATION; FLUSHING; HEART INFARCTION; HEART RUPTURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPERSENSITIVITY; HYPERTENSION; HYPOTENSION; INCIDENCE; INTOXICATION; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ATROPINE; CARDIOTONIC AGENTS; CORONARY ARTERY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMANS; INCIDENCE; PARASYMPATHOLYTICS;

EID: 77951446727     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.859264     Document Type: Review

References (140)

1. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:595-606.
2. Berthe C, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J, Kulbertus HE. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during do-butamine infusion. Am J Cardiol. 1986;58:1167-1172.
3. McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992; 70:41-46.
4. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation. 1993;88:15-19.
5. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M; Echo Dobu-tamine International Cooperative Study Group. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multi-centre study. Lancet. 1994;344:1190-1192.
6. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography, part II: dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc. 1995;70:16-27.
7. Zahn R, Lotter R, Nohl H, Schiele R, Bergmeier C, Zander M, Seidl K, Senges J. Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies [in German]. Z Kardiol. 1996;85:28-34.
8. Hiro J, Hiro T, Reid CL, Ebrahimi R, Matsuzaki M, Gardin JM. Safety and results of dobutamine stress echocardiography in women versus men and in patients older and younger than 75 years of age. Am J Cardiol. 1997;80:1014-1020.
9. Lamisse N, Cohen A, Chauvel C, Benhalima B, Desert I, Buyukoglu B, Blanchard B, Albo C, Boccara F, Valty J. Dobutamine stress echocar-diography: a monocentric experience on 600 consecutive patients: effect of age [in French]. Arch Mal Coeur Vaiss. 1997;90:1455-1461.
10. Pinton R, Lemke W, Garcia LG. Symptoms, complications and hemo-dynamic changes related to dobutamine stress echocardiography [in Portuguese]. Arq Bras Cardiol. 1997;69:161-164.
11. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD. Safety of dobutamine stress echocardiography in 474 consecutive studies. Coron Artery Dis. 1997;8:175-178.
12. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol. 1997;29:1234-1240.
13. Bremer ML, Monahan KH, Stussy VL, Miller FA Jr, Seward JB, Pellikka PA. Safety of dobutamine stress echocardiography supervised by registered nurse sonographers. J Am Soc Echocardiogr. 1998;11: 601-605.
14. Pezzano A, Gentile F, Mantero A, Morabito A, Ravizza P. RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations. G Ital Cardiol. 1998;28:102-111.
15. Plonska E, Szwed H, Gasior Z, Drozdz J, Gackowski A, Szyszka A, Sienko A, Flasinski J, Swiatkiewicz I, Sas M, Demczuk M, Kleinrok A, Krzyminska E. Side effects during dobutamine stress echocardiography: analysis of 582 studies [in Polish]. Pol Merkuriusz Lek. 1999;7: 164-168.
16. Mathias W Jr, Arruda A, Santos FC, Arruda AL, Mattos E, Osorio A, Campos O, Gil M, Andrade JL, Carvalho AC. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr. 1999;12:785-791.
17. Takeuchi M, Miura Y, Sonoda S, Kuroiwa A. Comparison of three different protocols for dobutamine stress echocardiography: does the addition of atropine increase complications, and does it improve diagnostic accuracy? Echocardiography. 1999;16:347-355.
18. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JR, Simoons ML. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation. 1999; 99:757-762.
19. Chenzbraun A, Khoury Z, Gottlieb S, Keren A. Impact of age on the safety and the hemodynamic response pattern during high dose dobuta-mine echocardiography. Echocardiography. 1999;16:135-142.
20. Hirano Y, Yamamoto T, Uehara H, Nakamura H, Wufuer M, Yamada S, Ikawa H, Ishikawa K. Complications of stress echocardiography [in Japanese]. J Cardiol. 2001;38:73-80.
21. Cortigiani L, Picano E, Coletta C, Chiarella F, Mathias W, Gandolfo N, De Alcantara M, Mazzoni V, Gensini GF, Landi P. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J. 2001; 141:621-629.
22. Rodriguez Garcia MA, Iglesias-Garriz I, Corral Fernandez F, Garrote Coloma C, Alonso-Orcajo N, Branco L, Picano E. Evaluation of the safety of stress echocardiography in Spain and Portugal [in Spanish]. Rev Esp Cardiol. 2001;54:941-948.
23. Tsutsui JM, Osorio AF, Lario FA, Fernandes DR, Sodre G, Andrade JL, Ramires JA, Mathias W Jr. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol. Am J Cardiol. 2004;94:1367-1372.
24. Abreu JS, Diogenes TC, Farias AG, Morais JM, Paes Junior JN. Safety and feasibility of dobutamine-atropine stress echocardiography in octogenarian patients [in Portuguese]. Arq Bras Cardiol. 2005;85:198-204.
25. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiog-raphy. J Am Coll Cardiol. 2005;45:1235-1242. (Pubitemid 40523143)
26. Timperley J, Mitchell AR, Thibault H, Mirza IH, Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr. 2005;18:163-167. (Pubitemid 40170045)
27. San Roman JA, Sanz-Ruiz R, Ortega JR, Perez-Paredes M, Rollan MJ, Munoz AC, Segura F, Jimenez D, Carnero A, Pinedo M, Arnold R, Gomez I, Fernandez-Aviles F. Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol. J Am Soc Echocardiogr. 2008;21:53-57.
28. Aggeli C, Giannopoulos G, Roussakis G, Christoforatou E, Marinos G, Toli C, Pitsavos C, Stefanadis C. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies. Heart. 2008;94:1571-1577.
29. Kane GC, Hepinstall MJ, Kidd GM, Kuehl CA, Murphy AT, Nelson JM, Schneider L, Stussy VL, Warmsbecker JA, Miller FA Jr, Pellikka PA, McCully RB. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echo-cardiogr. 2008;21:337-341.
30. Reisenhofer B, Squarcini G, Picano E. Cardiac rupture during dobuta-mine stress test. Ann Intern Med. 1998;128:605.
31. Orlandini AD, Tuero EI, Diaz R, Vilamajo OA, Paolasso EA. Acute cardiac rupture during dobutamine-atropine echocardiography stress test. J Am Soc Echocardiogr. 2000;13:152-153.
32. Zamorano J, Moreno R, Almeria C, Serra V, Rodrigo J, Sanchez-Harguindey L. Left ventricular free wall rupture during dobutamine stress echocardiography [in Spanish]. Rev Esp Cardiol. 2002;55: 312-314.
33. Datino T, Garcia-Fernandez MA, Martinez-Selles M, Quiles J, Avanzas P. Cardiac rupture during contrast-enhanced dobutamine stress echocar-diography. Int J Cardiol. 2005;98:349-350.
34. Daniels CJ, Orsinelli DA. Cardiac rupture with dobutamine stress echo-cardiography. J Am Soc Echocardiogr. 1997;10:979-981.
35. Nadeem SN, Hassan K, Kazmi KA, Sharif HM, O'Neill B. Cardiac rupture during stress echocardiography. Can J Cardiol. 2005;21: 1217-1219.
36. Oliva PB, Hammill SC, Edwards WD. Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol. 1993;22: 720-726.
37. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, Dzavik V, Greenberg M, Menegus M, Connery C, Hochman JS. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry: should we emer-gently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000;36:1117-1122.
38. Lewis WR, Arena FJ, Galloway MT, Bommer WJ. Acute myocardial infarction associated with dobutamine stress echocardiography. J Am Soc Echocardiogr. 1997;10:576-578.
39. Takeuchi M, Sonoda S, Hanada H, Numata T, Nakashima Y. Acute myocardial infarction in a patient during dobutamine stress echocardi-ography. Cathet Cardiovasc Diagn. 1997;41:404-406.
40. Weidmann B, Lepique CU, Jansen W, Stoiber WU, Tauchert MO. Myocardial infarction as a complication of dobutamine stress echocar-diography. J Am Soc Echocardiogr. 1997;10:768-771.
41. Pressman GS. Acute infarction of a previously stented coronary artery precipitated by dobutamine stress echocardiography. J Am Soc Echo-cardiogr. 2000;13:150-151.
42. Ferreira AC, de Marchena E, Mayor M, Bolooki H. Sinus of Valsalva aneurysm presenting as myocardial infarction during dobutamine stress test. Cathet Cardiovasc Diagn. 1996;39:400-402.
43. Breithardt OA, Flachskampf FA, Klues HG. Life threatening acute complications of dobutamine-atropine stress echocardiography: a case report [in German]. Z Kardiol. 1998;87:492-498.
44. Galloway MT, Paglieroni TG, Wun T, Arena FJ, Lewis WR. Platelet activation during dobutamine stress echocardiography. Am Heart J. 1998;135:888-900.
45. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W. Management of acute myo-cardial infarction in patients presenting with ST-segment elevation: the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
46. Takhtehchian DS, Novaro GM, Barnett G, Griffin BP, Pellikka PA. Safety of dobutamine stress echocardiography in patients with unruptured intracranial aneurysms. J Am Soc Echocardiogr. 2002;15: 1401-1404.
47. Cusick DA, Bonow RO, Chaudhry FA. Safety of dobutamine stress echocardiography in patients with left ventricular apical thrombus. Am J Cardiol. 1997;80:1252-1254.
48. Hacke W, Kaste M, Skyhoj Olsen T, Orgogozo JM, Bogousslavsky J; the European Stroke Initiative Writing Committee. European Stroke Initiative (EUSI) recommendations for stroke management. Eur J Neurol. 2000;7:607-623.
49. Lanzarini L, Previtali M, Diotallevi P. Syncope caused by cardiac asystole during dobutamine stress echocardiography. Heart. 1996;75: 320-321.
50. Salustri A, Biferali F, Palamara A. Cardiac arrest during dobutamine stress echocardiography. G Ital Cardiol. 1997;27:69-71.
51. Pinton R, Haggi Filho H, Lemke W, Franca Neto OR. Cardiac asystole during dobutamine stress echocardiography [in Portuguese]. Arq Bras Cardiol. 1998;70:435-436.
52. Hopfenspirger MR, Miller TD, Christian TF, Gibbons RJ. Sinus node deceleration during dobutamine perfusion scintigraphy as a marker of inferior ischemia. Am J Cardiol. 1994;74:817-819.
53. Attenhofer CH, Pellikka PA, McCully RB, Roger VL, Seward JB. Paradoxical sinus deceleration during dobutamine stress echocardiogra-phy: description and angiographic correlation. J Am Coll Cardiol. 1997; 29:994-999.
54. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1: 90-102.
55. Waxman MB, Asta JA, Cameron DA. Vasodepressor reaction induced by inferior vena cava occlusion and isoproterenol in the rat: role of beta 1-and beta 2-adrenergic receptors. Circulation. 1994;89:2401-2411.
56. Pontillo D, Capezzuto A. Dobutamine, dipyridamole, and stress echo-cardiography. Circulation. 1996;93:617.
57. Varga A, Picano E, Lakatos F. Fatal ventricular fibrillation during a low-dose dobutamine stress test. Am J Med. 2000;108:352-353.
58. Shaheen J, Mendzelevski B, Tzivoni D. Dobutamine-induced ST segment elevation and ventricular fibrillation with nonsignificant coronary artery disease. Am Heart J. 1996;132:1058-1060.
59. Jiamsripong P, Honda T, McCully R, Khandheria BK, Mookadam F. Ventricular fibrillation in late recovery after dobutamine stress echocar-diography. J Am Soc Echocardiogr. 2007;20:1220 e1227-e1210.
60. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH, Arnese M, Roelandt RT. Safety of dobutamine-atropine stress echo-cardiography in patients with suspected or proven coronary artery disease. Am J Cardiol. 1994;73:456-459.
61. De Sutter J, Poldermans D, Vourvouri E, Van Donburg R, Elhendy A, Bax J, Sozzi F, Jordaens L, De Buyzere M, Roelandt J. Long-term prognostic significance of complex ventricular arrhythmias induced during dobutamine stress echocardiography. Am J Cardiol. 2003;91: 242-244.
62. Bigi R, Partesana N, Verzoni A, Bandini P, Maffi M, Longoni A, Occhi G, Fiorentini C. Incidence and correlates of complex ventricular arrhythmias during dobutamine stress echocardiography after acute myocardial infarction. Eur Heart J. 1995;16:1819-1824.
63. Elhendy A, van Domburg RT, Bax JJ, Roelandt JR. Relation between the extent of coronary artery disease and tachyarrhythmias during do-butamine stress echocardiography. Am J Cardiol. 1999;83:832-835.
64. Madu EC, Price A, Harris T, Badran H, Rouse C, Ramanathan KB. Sustained nonischemic ventricular tachycardia during dobutamine stress echocardiography. Cardiology. 1996;87:82-85.
65. Poldermans D, ten Cate FJ, Elhendy A, Rocchi G, Bax JJ, Vletter W, Roelandt JR. Ventricular tachycardia during dobutamine stress myo-cardial contrast imaging. Chest. 1999;115:307-308.
66. Previtali M, Lanzarini L, Fetiveau R, Poli A, Diotallevi P. Dobutamine-induced and spontaneous sustained ventricular tachycardia in recent myocardial infarction. Eur Heart J. 1996;17:803-804.
67. John RM, Taggart PI, Sutton PM, Ell PJ, Swanton H. Direct effect of dobutamine on action potential duration in ischemic compared with normal areas in the human ventricle. J Am Coll Cardiol. 1992;20: 896-903.
68. O'Sullivan CA, Henein MY, Sutton R, Coats AJ, Sutton GC, Gibson DG. Abnormal ventricular activation and repolarisation during dobuta-mine stress echocardiography in coronary artery disease. Heart. 1998; 79:468-473.
69. Brodde OE, O'Hara N, Zerkowski HR, Rohm N. Human cardiac beta-adrenoceptors: both beta 1-and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium. J Cardiovasc Pharmacol. 1984;6:1184-1191.
70. Priori SG, Corr PB. Mechanisms underlying early and delayed afterde-polarizations induced by catecholamines. Am J Physiol. 1990;258: H1796-H1805.
71. Coma-Canella I. Changes in plasma potassium during the dobutamine stress test. Int J Cardiol. 1991;33:55-59.
72. Cornel JH, Balk AH, Boersma E, Maat AP, Elhendy A, Arnese M, Salustri A, Roelandt JR, Fioretti PM. Safety and feasibility of dobuta-mine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr. 1996;9:27-32.
73. Cox DE, Farmer LD, Hoyle JR, Wells GL. Prognostic significance of nonsustained ventricular tachycardia during dobutamine stress echocar-diography. Am J Cardiol. 2005;96:1293-1298.
74. Mathias Junior W, Beneti LP, dos Santos FC, Duprat R, Beraldo A, Gil MA, Andrade JL, Martinez E. Safety and feasibility of dobutamine-atropine stress echocardiography [in Portuguese]. Arq Bras Cardiol. 1997;69:31-34.
75. Schreck DM, Rivera AR, Tricarico VJ. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann Emerg Med. 1997;29:135-140.
76. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine: basic and clinical concepts. Circulation. 1991;83:1499-1509.
77. Hung KC, Lin FC, Chern MS, Chang HJ, Hsieh IC, Wu D. Mechanisms and clinical significance of transient atrioventricular block during do-butamine stress echocardiography. J Am Coll Cardiol. 1999;34: 998-1004.
78. Wellens HJJ. The ECG in Emergency Decision-Making. 2nd ed. Maastricht, the Netherlands: Elsevier Saunders; 2006:72.
79. Varga A, Cortigiani L, Rossi PC, Cseh E, De Nes M, Trivieri MG, Csanady M, Picano E. Coronary vasospasm as a source of false positive results during dobutamine echocardiography. Cardiologia. 1999;44: 907-912.
80. Alvarez L, Zamorano J, Mataix L, Almeria C, Moreno R, Rodrigo JL. Coronary spasm after administration of propranolol during dobutamine stress echocardiography [in Spanish]. Rev Esp Cardiol. 2002;55: 778-781.
81. Deligonul U, Armbruster R, Hailu A. Provocation of coronary spasm by dobutamine stress echocardiography in a patient with angiographically minimal coronary artery disease. Clin Cardiol. 1996;19:755-758.
82. Roffi M, Meier B, Allemann Y. Angiographic documented coronary arterial spasm in absence of critical coronary artery stenoses in a patient with variant angina episodes during exercise and dobutamine stress echocardiography. Heart. 2000;83:E4.
83. Cohen A, Chauvel C, Benhalima B, Blanchard B. Complication of dobutamine stress echocardiography. Lancet. 1995;345:201-202.
84. Mathew J, Thannoli N, Narra L, el Khadra M. Transmural myocardial ischaemia during dobutamine stress echocardiography. Lancet. 1995; 346:383-384.
85. Yamagishi H, Watanabe H, Toda I, Yoshiyama M, Akioka K, Teragaki M, Takeuchi K, Yoshikawa J. A case of dobutamine-induced coronary arterial spasm with ST-segment elevation. Jpn Circ J. 1998;62: 150-151.
86. Tio RA, Van Gelder IC, Boonstra PW, Crijns HJ. Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary Doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart. 1997;77:280-282.
87. Kawano H, Fujii H, Motoyama T, Kugiyama K, Ogawa H, Yasue H. Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography. Am J Cardiol. 2000;85:26-30.
88. Dai XZ, Chen DG, Bache RJ. Alpha-adrenergic effects of dopamine and dobutamine on the coronary circulation. J Cardiovasc Pharmacol. 1989; 14:82-87.
89. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation. 1992;85:905-909.
90. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
91. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol. 1989;63:17-20.
92. Kamalesh M, Chandrasekaran K, Sivaram CA, Thadani U. Lack of arrhythmogenicity with ST-segment elevation during high-dose of do-butamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997;80:341-343.
93. Elhendy A, Cornel JH, Roelandt JR, van Domburg RT, Geleijnse MI, Nierop PR, Bax JJ, Sciarra A, Ibrahim MM, el-Refaee M, el-Said GM, Fioretti PM. Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction. Heart. 1997;77:115-121.
94. Coma-Canella I. Dobutamine stress test to diagnose the presence and severity of coronary artery lesions in angina. Eur Heart J. 1991;12: 1198-1204.
95. Previtali M, Lanzarini L, Mussini A, Ferrario M, Angoli L, Specchia G. Dobutamine-induced ST segment elevation in a patient with angina at rest and critical coronary lesions. Eur Heart J. 1992;13:997-999.
96. Previtali M, Fetiveau R, Lanzarini L, Cavalotti C. Dobutamine-induced ST-segment elevation in patients without myocardial infarction. Am J Cardiol. 1998;82:1528-1530, A7.
97. Arruda AL, Barretto RB, Shub C, Chandrasekaran K, Pellikka PA. Prognostic significance of ST-segment elevation during dobutamine stress echocardiography. Am Heart J. 2006;151:744 e741-744 e746.
98. Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am Coll Cardiol. 1993;21: 1080-1086.
99. Geleijnse ML, Elhendy A, van Domburg RT, Rambaldi R, Reijs AE, Roelandt JR, Fioretti PM. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol. 1997;79:1031-1035.
100. Lieberman EB, Heinle SK, Wildermann N, Waugh RA, Kisslo JA, Bashore TM. Does hypotension during dobutamine stress echocardiog-raphy correlate with anatomic or functional cardiac impairment? Am Heart J. 1995;129:1121-1126.
101. Heinle SK, Tice FD, Kisslo J. Hypotension during dobutamine stress echocardiography: is it related to dynamic intraventricular obstruction? Am Heart J. 1995;130:314-317.
102. Rallidis LS, Moyssakis IE, Nihoyannopoulos P. Hypotensive response during dobutamine stress echocardiography in coronary patients: a common event of well-functioning left ventricle. Clin Cardiol. 1998;21: 747-752.
103. Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik AJ. Dynamic intraventricular obstruction during dobutamine stress echocar-diography: a new observation. Circulation. 1992;86:1429-1432.
104. Khanal S, Daggubati R, Gaalla A, Shah PM, Pai RG. Left ventricular cavity obliteration during dobutamine stress echocardiography is associated with female sex and left ventricular size and function. J Am Soc Echocardiogr. 1998;11:957-960.
105. Luria D, Klutstein MW, Rosenmann D, Shaheen J, Sergey S, Tzivoni D. Prevalence and significance of left ventricular outflow gradient during dobutamine echocardiography. Eur Heart J. 1999;20:386-392.
106. Sorrentino MJ, Marcus RH, Lang RM. Left ventricular outflow tract obstruction as a cause for hypotension and symptoms during dobutamine stress echocardiography. Clin Cardiol. 1996;19:225-230.
107. Wang CH, Cherng WJ, Hung MJ. Dobutamine-induced hypotension is an independent predictor for mortality in patients with left ventricular dysfunction following myocardial infarction. Int J Cardiol. 1999;68: 297-302.
108. Elhendy A, van Domburg RT, Nierop PR, Geleijnse ML, Bax JJ, Kasprzak JD, Liqui-Lung AF, Ibrahim MM, Roelandt JR. Impaired systolic blood pressure response to dobutamine stress testing: a marker of more severe functional abnormalities in patients with myocardial infarction. J Am Soc Echocardiogr. 1998;11:436-441.
109. Lee CY, Pellikka PA, Shub C, Sinak LJ, Seward JB. Hypertensive response during dobutamine stress echocardiography. Am J Cardiol. 1997;80:970-971.
110. Cayen B, Cullen N. Intracerebral haemorrhage in previously healthy adults following aerobic and anaerobic exercise. Brain Inj. 2002;16: 397-405.
111. Pestalozzi BC, Caduff F. Group poisoning by belladonna [in German]. Schweiz Med Wochenschr. 1986;116:924-926.
112. Myles P. Dobutamine-atropine stress echocardiography and central anti-cholinergic syndrome. Lancet. 1994;344:1636.
113. Hoff JV, Peatty PA, Wade JL. Dermal necrosis from dobutamine. N Engl J Med. 1979;300:1280.
114. Leier CV, Webel J, Bush CA. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation. 1977;56:468-472.
115. MacCara ME. Extravasation: a hazard of intravenous therapy. Drug Intell Clin Pharm. 1983;17:713-717.
116. Wu CC, Chen WJ, Cheng JJ, Hsieh YY, Lien WP. Local dermal hypersensitivity from dobutamine hydrochloride (Dobutrex solution) injection. Chest. 1991;99:1547-1548.
117. McCauley CS, Blumenthal MS. Dobutamine and pruritus of the scalp. Ann Intern Med. 1986;105:966.
118. Cernek PK. Dermal cellulitis: a hypersensitivity reaction from dobuta-mine hydrochloride. Ann Pharmacother. 1994;28:964.
119. Epailly E, Blaumeiser M, Gonzales M, Cantineau A. Suspicion of asthma due to dobutamine chlorhydrate: apropos of a case [in French]. Therapie. 1994;49:52-53.
120. Smolinske SC. Review of parenteral sulfite reactions. J Toxicol Clin Toxicol. 1992;30:597-606.
121. Lattanzi F, Picano E, Adamo E, Varga A. Dobutamine stress echocar-diography: safety in diagnosing coronary artery disease. Drug Saf. 2000;22:251-262.
122. Varga A, Garcia MA, Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol. 2006;98:541-543.
123. Stuart RJ Jr, Ellestad MH. National survey of exercise stress testing facilities. Chest. 1980;77:94-97.
124. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti G, Chiarella F, Orlandini A, Seveso G, Colosso MQ, Sclavo MG, Ornella Magaia O, Agati L, Previtali M, Lowenstein J, Torre F, Rosselli P, Ciuti M, Ostojic M, Gandolfo N, Margaria F, Giannuzzi P, Di Bello V, Lombardi M, Gigli G, Ferrara N, Santoro F, Lusa AM, Chiaranda' G, Papagna D, Coletta C, Boccardi L, De Cristofaro M, Papi L, Landi P; the Echo-Persantine International Cooperative Study Group. Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol. 1992;70:252-258.
125. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, Stanton EB, Bom HS, Leppo J, Nattel S. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol. 1995;2:3-17.
126. Deckers JW, Fioretti P, Brower RW, Simoons ML, Baardman T, Hugenholtz PG. Ineligibility for predischarge exercise testing after myo-cardial infarction in the elderly: implications for prognosis. Eur Heart J. 1984;5(suppl E):97-100.
127. Froelicher VF, Perdue S, Pewen W, Risch M. Application of meta-analysis using an electronic spread sheet to exercise testing in patients after myocardial infarction. Am J Med. 1987;83:1045-1054.
128. Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 1987;76:943-951.
129. Geleijnse ML, Marwick TH, Boersma E, Deckers JW, Melin JA, Fioretti PM. Optimal pharmacological stress testing for the diagnosis of coronary artery disease: a probabilistic approach. Eur Heart J. 1995; 16(suppl M):3-10.
130. Elhendy A, Windle J, Porter TR. Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators. Am J Cardiol. 2003;92:475-477.
131. Pellikka PA, Roger VL, Oh JK, Seward JB, Tajik AJ. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter. Am J Cardiol. 1996;77: 413-416.
132. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.
133. Baptista J, Arnese M, Roelandt JR, Fioretti P, Keane D, Escaned J, Boersma E, di Mario C, Serruys PW. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: correlations with dobutamine-atropine stress test. J Am Coll Cardiol. 1994;23:1434-1439.
134. Franklin BA, Gordon S, Timmis GC, O'Neill WW. Is direct physician supervision of exercise stress testing routinely necessary? Chest. 1997; 111:262-265.
135. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, Marwick TH, McCallister BD, Thompson PD Jr, Winters WL, Yanowitz FG, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Lewis RP, O'Rourke RA, Ryan TJ. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997; 30:260-311.
136. Panza JA, Curiel RV, Laurienzo JM, Quyyumi AA, Dilsizian V. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with coronary artery disease. Circulation. 1995;92:2095-2101.
137. Poldermans D, Arnese M, Fioretti PM, Salustri A, Boersma E, Thomson IR, Roelandt JR, van Urk H. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol. 1995;26:648-653.
138. Dolan MS, Riad K, El-Shafei A, Puri S, Tamirisa K, Bierig M, St Vrain J, McKinney L, Havens E, Habermehl K, Pyatt L, Kern M, Labovitz AJ. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J. 2001;142:908-915.
139. Dijkmans PA, Visser CA, Kamp O. Adverse reactions to ultrasound contrast agents: is the risk worth the benefit? Eur J Echocardiogr. 2005;6:363-366.
140. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol. 2009;53:32-38.